AgingResearch.News
AHA Scientific Sessions 2025 Abstract

Acoramidis Reduces All-Cause Mortality and First Cardiovascular Hospitalization in Patients with Variant Transthyretin Amyloid Cardiomyopathy: Results From the ATTRibute-CM Study

By Margot K. Davis, Jan M. Griffin, Nitasha Sarswat, Show 14 more authorsMartha A. Grogan
Trial in peopleInterventions
Paper

The paper

Margot K. Davis, Jan M. Griffin, Nitasha Sarswat, Show 14 more authorsMartha A. Grogan

University of British Columbia; Mayo Clinic

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4368295

doi.org/10.1161/circ.152.suppl_3.4368295

Related